File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1113/jphysiol.1996.sp021515
- Scopus: eid_2-s2.0-0029793984
- PMID: 8842014
- WOS: WOS:A1996VA38000022
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: On muscarinic control of neurogenic mucus secretion in ferret trachea
Title | On muscarinic control of neurogenic mucus secretion in ferret trachea |
---|---|
Authors | |
Issue Date | 1996 |
Publisher | Wiley-Blackwell Publishing Ltd.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0022-3751 |
Citation | Journal Of Physiology, 1996, v. 494 n. 2, p. 577-586 How to Cite? |
Abstract | 1. Muscarinic receptor subtypes mediating neurogenic mucus secretion in ferret trachea were characterized in vitro and in vivo using 35SO4 as a label for secreted mucus, and the muscarinic receptor antagonists telenzepine for the M1 receptor subtype, methoctramine for the M2 subtype and 4-diphenylacetoxy-N-methylpiperidine methobromide (4-DAMP) for the M3 receptor. We also performed receptor binding and mapping studies. 2. Each muscarinic antagonist displaced [N-methyl-3H]scopolamine binding with high=affinity binding constant (K(H)) values of 1.9, 2.7 and 5.0 nm for telenzepine, methoctramine and 4-DAMP, respectively. Muscarinic M1 and M3 receptors localized to submucosal glands, whereas M2 receptors did not. 3. In vitro, electrical stimulation (50 V, 10 Hz, 0.5ms for 5 min) increased 35SO4 output by 160%. Telenzepine did not inhibit the neurogenic secretory response at concentrations two- or twentyfold its K(H) value, nor did it inhibit secretion induced by acetylcholine (ACh). 4-DAMP inhibited neurogenic secretion by 80% and 95%, respectively, at concentrations two- and twentyfold its K(H) value, and also limited ACh-induced secretion. Methoctramine potentiated neurogenic secretion induced at 2.5 Hz (50 V, 0.5 ms for 5 min) in a dose-related (5.4-100 nM) manner with increases of 35-451% above electrically stimulated values. Methoctramine did not potentiate secretion induced at 10 Hz and did not have any effect on ACh-induced secretion. 4. In vivo, vagal stimulation(10 V, 10 Hz, 2 ms for 8 min) increased output of 35SO4 by ~120%. telenzepine had no significant effect on neurogenic secretion. Methoctramine approximately doubled the stimulated response, whereas 4-DAMP abolished the stimulated secretory response. 5. We conclude that in ferret trachea, cholinergic nerve stimulation increases mucus secretion via muscarinic M3 receptors on the submucosal glands. The magnitude of the secretory response is regulated by neuronal M2 muscarinic receptors. The muscarinic M1 receptors localized to the submucosal glands do not appear to be involved with mucus secretion. |
Persistent Identifier | http://hdl.handle.net/10722/162125 |
ISSN | 2023 Impact Factor: 4.7 2023 SCImago Journal Rankings: 1.708 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ramnarine, SI | en_US |
dc.contributor.author | Haddad, EB | en_US |
dc.contributor.author | Khawaja, AM | en_US |
dc.contributor.author | Mak, JCW | en_US |
dc.contributor.author | Rogers, DF | en_US |
dc.date.accessioned | 2012-09-05T05:17:29Z | - |
dc.date.available | 2012-09-05T05:17:29Z | - |
dc.date.issued | 1996 | en_US |
dc.identifier.citation | Journal Of Physiology, 1996, v. 494 n. 2, p. 577-586 | en_US |
dc.identifier.issn | 0022-3751 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/162125 | - |
dc.description.abstract | 1. Muscarinic receptor subtypes mediating neurogenic mucus secretion in ferret trachea were characterized in vitro and in vivo using 35SO4 as a label for secreted mucus, and the muscarinic receptor antagonists telenzepine for the M1 receptor subtype, methoctramine for the M2 subtype and 4-diphenylacetoxy-N-methylpiperidine methobromide (4-DAMP) for the M3 receptor. We also performed receptor binding and mapping studies. 2. Each muscarinic antagonist displaced [N-methyl-3H]scopolamine binding with high=affinity binding constant (K(H)) values of 1.9, 2.7 and 5.0 nm for telenzepine, methoctramine and 4-DAMP, respectively. Muscarinic M1 and M3 receptors localized to submucosal glands, whereas M2 receptors did not. 3. In vitro, electrical stimulation (50 V, 10 Hz, 0.5ms for 5 min) increased 35SO4 output by 160%. Telenzepine did not inhibit the neurogenic secretory response at concentrations two- or twentyfold its K(H) value, nor did it inhibit secretion induced by acetylcholine (ACh). 4-DAMP inhibited neurogenic secretion by 80% and 95%, respectively, at concentrations two- and twentyfold its K(H) value, and also limited ACh-induced secretion. Methoctramine potentiated neurogenic secretion induced at 2.5 Hz (50 V, 0.5 ms for 5 min) in a dose-related (5.4-100 nM) manner with increases of 35-451% above electrically stimulated values. Methoctramine did not potentiate secretion induced at 10 Hz and did not have any effect on ACh-induced secretion. 4. In vivo, vagal stimulation(10 V, 10 Hz, 2 ms for 8 min) increased output of 35SO4 by ~120%. telenzepine had no significant effect on neurogenic secretion. Methoctramine approximately doubled the stimulated response, whereas 4-DAMP abolished the stimulated secretory response. 5. We conclude that in ferret trachea, cholinergic nerve stimulation increases mucus secretion via muscarinic M3 receptors on the submucosal glands. The magnitude of the secretory response is regulated by neuronal M2 muscarinic receptors. The muscarinic M1 receptors localized to the submucosal glands do not appear to be involved with mucus secretion. | en_US |
dc.language | eng | en_US |
dc.publisher | Wiley-Blackwell Publishing Ltd.. The Journal's web site is located at http://www.wiley.com/bw/journal.asp?ref=0022-3751 | en_US |
dc.relation.ispartof | Journal of Physiology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Diamines - Pharmacology | en_US |
dc.subject.mesh | Electric Stimulation | en_US |
dc.subject.mesh | Ferrets | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mucus - Secretion | en_US |
dc.subject.mesh | Muscarinic Antagonists - Pharmacology | en_US |
dc.subject.mesh | Muscle, Smooth - Drug Effects - Innervation - Physiology | en_US |
dc.subject.mesh | Piperidines - Pharmacology | en_US |
dc.subject.mesh | Pirenzepine - Analogs & Derivatives - Pharmacology | en_US |
dc.subject.mesh | Quinuclidinyl Benzilate - Metabolism | en_US |
dc.subject.mesh | Radioligand Assay | en_US |
dc.subject.mesh | Receptors, Muscarinic - Drug Effects - Physiology | en_US |
dc.subject.mesh | Scopolamine Hydrobromide - Metabolism | en_US |
dc.subject.mesh | Sulfates - Metabolism | en_US |
dc.subject.mesh | Sulfur Radioisotopes | en_US |
dc.subject.mesh | Trachea - Drug Effects - Innervation - Physiology | en_US |
dc.subject.mesh | Tritium | en_US |
dc.title | On muscarinic control of neurogenic mucus secretion in ferret trachea | en_US |
dc.type | Article | en_US |
dc.identifier.email | Mak, JCW:judymak@hku.hk | en_US |
dc.identifier.authority | Mak, JCW=rp00352 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1113/jphysiol.1996.sp021515 | - |
dc.identifier.pmid | 8842014 | - |
dc.identifier.scopus | eid_2-s2.0-0029793984 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0029793984&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 494 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | 577 | en_US |
dc.identifier.epage | 586 | en_US |
dc.identifier.isi | WOS:A1996VA38000022 | - |
dc.publisher.place | United Kingdom | en_US |
dc.identifier.scopusauthorid | Ramnarine, SI=16158344500 | en_US |
dc.identifier.scopusauthorid | Haddad, EB=7102803008 | en_US |
dc.identifier.scopusauthorid | Khawaja, AM=7003931509 | en_US |
dc.identifier.scopusauthorid | Mak, JCW=7103323094 | en_US |
dc.identifier.scopusauthorid | Rogers, DF=7402049007 | en_US |
dc.identifier.issnl | 0022-3751 | - |